Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for WT1_MTF1_ZBTB7B
Z-value: 0.11
Motif logo
Transcription factors associated with WT1_MTF1_ZBTB7B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WT1
|
ENSG00000184937.8 | WT1 transcription factor |
|
MTF1
|
ENSG00000188786.9 | metal regulatory transcription factor 1 |
|
ZBTB7B
|
ENSG00000160685.9 | zinc finger and BTB domain containing 7B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZBTB7B | hg19_v2_chr1_+_154975110_154975149 | -0.66 | 3.6e-05 | Click! |
| MTF1 | hg19_v2_chr1_-_38325256_38325292 | -0.33 | 6.2e-02 | Click! |
| WT1 | hg19_v2_chr11_-_32452357_32452363 | 0.31 | 8.1e-02 | Click! |
Activity profile of WT1_MTF1_ZBTB7B motif
Sorted Z-values of WT1_MTF1_ZBTB7B motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr4_-_819901 | 21.62 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
| chr4_-_819880 | 20.51 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
| chr22_+_51112800 | 17.24 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
| chr19_-_291365 | 14.12 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr16_+_87636474 | 14.07 |
ENST00000284262.2
|
JPH3
|
junctophilin 3 |
| chr22_+_48972118 | 13.31 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
| chr14_+_102027688 | 12.97 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr17_+_30593195 | 12.57 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr19_+_708910 | 12.49 |
ENST00000264560.7
|
PALM
|
paralemmin |
| chr19_+_709101 | 12.27 |
ENST00000338448.5
|
PALM
|
paralemmin |
| chr9_+_132934835 | 11.65 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
| chr11_-_12030681 | 11.52 |
ENST00000529338.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr11_-_12030629 | 11.50 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr19_-_18717627 | 11.49 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
| chr14_-_53417732 | 11.35 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr4_+_150999418 | 10.56 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
| chr21_+_47063590 | 10.32 |
ENST00000400314.1
|
PCBP3
|
poly(rC) binding protein 3 |
| chr1_-_1475737 | 10.29 |
ENST00000378733.4
ENST00000425828.1 |
TMEM240
|
transmembrane protein 240 |
| chr16_+_58497567 | 10.26 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
| chr11_-_12030746 | 10.02 |
ENST00000533813.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr6_+_19837592 | 10.01 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| chr10_-_79397391 | 10.01 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr8_+_136469684 | 9.67 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
| chr4_-_5894777 | 9.66 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
| chr2_-_241759622 | 9.65 |
ENST00000320389.7
ENST00000498729.2 |
KIF1A
|
kinesin family member 1A |
| chr15_+_80696666 | 9.65 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
| chr2_+_220306745 | 9.59 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
| chr2_-_233792837 | 9.58 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
| chr4_-_6565315 | 9.57 |
ENST00000506140.1
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr12_+_58005204 | 9.49 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chr19_-_49944806 | 9.46 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
| chr17_+_37783453 | 9.25 |
ENST00000579000.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr2_+_14772810 | 9.15 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr4_+_1795012 | 9.15 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr19_+_55795493 | 9.14 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr2_+_42275153 | 9.08 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
| chr6_-_11044509 | 8.90 |
ENST00000354666.3
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
| chr14_+_33408449 | 8.85 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
| chr22_+_29279552 | 8.81 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chr22_-_38851205 | 8.79 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
| chr19_-_51071302 | 8.79 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
| chr19_-_460996 | 8.77 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
| chrX_-_152939133 | 8.74 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chrX_-_152939780 | 8.40 |
ENST00000370142.1
ENST00000393831.2 ENST00000447676.2 |
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chrX_-_152939252 | 8.35 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr7_-_140340576 | 8.34 |
ENST00000275884.6
ENST00000475837.1 |
DENND2A
|
DENN/MADD domain containing 2A |
| chr22_+_45898712 | 8.32 |
ENST00000455233.1
ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1
|
fibulin 1 |
| chr11_+_369804 | 8.22 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
| chr20_+_36531499 | 8.22 |
ENST00000373458.3
ENST00000373461.4 ENST00000373459.4 |
VSTM2L
|
V-set and transmembrane domain containing 2 like |
| chr20_+_34742650 | 8.16 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr16_+_1203194 | 8.11 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr20_-_62103862 | 8.08 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
| chr12_+_133195356 | 8.08 |
ENST00000389110.3
ENST00000449132.2 ENST00000343948.4 ENST00000352418.4 ENST00000350048.5 ENST00000351222.4 ENST00000348800.5 ENST00000542301.1 ENST00000536121.1 |
P2RX2
|
purinergic receptor P2X, ligand-gated ion channel, 2 |
| chr6_+_1389989 | 8.02 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
| chr1_+_1950763 | 8.02 |
ENST00000378585.4
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta |
| chr14_+_69726656 | 8.00 |
ENST00000337827.4
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr9_+_130374537 | 7.98 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
| chr5_+_1008910 | 7.97 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
| chr9_+_137979506 | 7.96 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
| chr1_-_31381528 | 7.92 |
ENST00000339394.6
|
SDC3
|
syndecan 3 |
| chr19_-_46476791 | 7.89 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
| chr14_-_102026643 | 7.86 |
ENST00000555882.1
ENST00000554441.1 ENST00000553729.1 ENST00000557109.1 ENST00000557532.1 ENST00000554694.1 ENST00000554735.1 ENST00000555174.1 ENST00000557661.1 |
DIO3OS
|
DIO3 opposite strand/antisense RNA (head to head) |
| chr1_+_6845384 | 7.83 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr14_-_105635090 | 7.83 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
| chr1_-_20812690 | 7.82 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr10_+_134000404 | 7.80 |
ENST00000338492.4
ENST00000368629.1 |
DPYSL4
|
dihydropyrimidinase-like 4 |
| chr22_+_51039098 | 7.79 |
ENST00000399912.1
ENST00000329492.3 ENST00000442429.2 ENST00000341339.4 |
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2 |
| chr16_+_58497587 | 7.79 |
ENST00000569404.1
ENST00000569539.1 ENST00000564126.1 ENST00000565304.1 ENST00000567667.1 |
NDRG4
|
NDRG family member 4 |
| chr16_-_325910 | 7.77 |
ENST00000359740.5
ENST00000316163.5 ENST00000431291.2 ENST00000397770.3 ENST00000397768.3 |
RGS11
|
regulator of G-protein signaling 11 |
| chr12_+_26111823 | 7.74 |
ENST00000381352.3
ENST00000535907.1 ENST00000405154.2 |
RASSF8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
| chr22_+_43808014 | 7.73 |
ENST00000334209.5
ENST00000443721.1 ENST00000414469.2 ENST00000439548.1 |
MPPED1
|
metallophosphoesterase domain containing 1 |
| chr11_-_12030905 | 7.73 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr19_-_7990991 | 7.70 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr16_-_49890016 | 7.68 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
| chr17_+_64961026 | 7.61 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
| chr5_+_131593364 | 7.54 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
| chr6_+_44238203 | 7.50 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
| chr2_+_56411131 | 7.48 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
| chr12_+_50355647 | 7.48 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
| chr16_+_330581 | 7.46 |
ENST00000219409.3
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
| chr17_+_79989500 | 7.45 |
ENST00000306897.4
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr19_-_47922373 | 7.44 |
ENST00000559524.1
ENST00000557833.1 ENST00000558555.1 ENST00000561293.1 ENST00000441740.2 |
MEIS3
|
Meis homeobox 3 |
| chr5_-_11904152 | 7.43 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr18_+_33877654 | 7.43 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr9_-_13279406 | 7.42 |
ENST00000546205.1
|
MPDZ
|
multiple PDZ domain protein |
| chr2_+_105471969 | 7.39 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr17_+_37783170 | 7.30 |
ENST00000254079.4
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr4_-_6474173 | 7.30 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr15_+_73976545 | 7.28 |
ENST00000318443.5
ENST00000537340.2 ENST00000318424.5 |
CD276
|
CD276 molecule |
| chr2_-_230579185 | 7.26 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr3_+_181429704 | 7.25 |
ENST00000431565.2
ENST00000325404.1 |
SOX2
|
SRY (sex determining region Y)-box 2 |
| chr8_-_145911188 | 7.22 |
ENST00000540274.1
|
ARHGAP39
|
Rho GTPase activating protein 39 |
| chr17_+_42836329 | 7.20 |
ENST00000200557.6
|
ADAM11
|
ADAM metallopeptidase domain 11 |
| chr2_-_1748214 | 7.19 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr12_-_120806960 | 7.17 |
ENST00000257552.2
|
MSI1
|
musashi RNA-binding protein 1 |
| chr19_-_821931 | 7.13 |
ENST00000359894.2
ENST00000520876.3 ENST00000519502.1 |
LPPR3
|
hsa-mir-3187 |
| chr4_-_5890145 | 7.08 |
ENST00000397890.2
|
CRMP1
|
collapsin response mediator protein 1 |
| chr10_-_125651258 | 7.07 |
ENST00000241305.3
|
CPXM2
|
carboxypeptidase X (M14 family), member 2 |
| chr19_-_47975106 | 7.06 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr8_-_144241432 | 7.00 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr19_+_589893 | 6.99 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr10_+_124221036 | 6.98 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr19_-_47922750 | 6.90 |
ENST00000331559.5
|
MEIS3
|
Meis homeobox 3 |
| chr9_-_112083229 | 6.87 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
| chr14_+_69726864 | 6.87 |
ENST00000448469.3
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr11_+_101981423 | 6.86 |
ENST00000531439.1
|
YAP1
|
Yes-associated protein 1 |
| chr7_+_128431444 | 6.86 |
ENST00000459946.1
ENST00000378685.4 ENST00000464832.1 ENST00000472049.1 ENST00000488925.1 |
CCDC136
|
coiled-coil domain containing 136 |
| chr10_-_134599556 | 6.85 |
ENST00000368592.5
|
NKX6-2
|
NK6 homeobox 2 |
| chr9_-_13279589 | 6.84 |
ENST00000319217.7
|
MPDZ
|
multiple PDZ domain protein |
| chr20_-_43438912 | 6.81 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
| chr14_+_69726968 | 6.81 |
ENST00000553669.1
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr9_+_17579084 | 6.80 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chr11_-_46940074 | 6.80 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
| chr16_+_226658 | 6.77 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
| chr5_-_11904100 | 6.77 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr8_-_144241664 | 6.75 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr14_-_103987679 | 6.75 |
ENST00000553610.1
|
CKB
|
creatine kinase, brain |
| chr7_+_121513374 | 6.74 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr20_-_55841662 | 6.73 |
ENST00000395863.3
ENST00000450594.2 |
BMP7
|
bone morphogenetic protein 7 |
| chr19_+_50706866 | 6.73 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
| chr4_+_2061119 | 6.73 |
ENST00000423729.2
|
NAT8L
|
N-acetyltransferase 8-like (GCN5-related, putative) |
| chr15_-_83316254 | 6.70 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr19_+_11650709 | 6.70 |
ENST00000586059.1
|
CNN1
|
calponin 1, basic, smooth muscle |
| chr20_-_55841398 | 6.67 |
ENST00000395864.3
|
BMP7
|
bone morphogenetic protein 7 |
| chr1_-_6546001 | 6.67 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr15_-_74045088 | 6.65 |
ENST00000569673.1
|
C15orf59
|
chromosome 15 open reading frame 59 |
| chr7_-_44365020 | 6.63 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr6_-_46459099 | 6.62 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
| chr7_-_19157248 | 6.59 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
| chr8_+_27491572 | 6.58 |
ENST00000301904.3
|
SCARA3
|
scavenger receptor class A, member 3 |
| chr11_+_66045634 | 6.58 |
ENST00000528852.1
ENST00000311445.6 |
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2 |
| chr6_+_17393839 | 6.51 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr19_-_11591848 | 6.51 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
| chr3_-_183979251 | 6.50 |
ENST00000296238.3
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
| chr19_+_15218180 | 6.47 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
| chr19_+_7660716 | 6.46 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr2_+_235860690 | 6.46 |
ENST00000416021.1
|
SH3BP4
|
SH3-domain binding protein 4 |
| chr8_+_30241995 | 6.45 |
ENST00000397323.4
ENST00000339877.4 ENST00000320203.4 ENST00000287771.5 |
RBPMS
|
RNA binding protein with multiple splicing |
| chr19_-_1237990 | 6.42 |
ENST00000382477.2
ENST00000215376.6 ENST00000590083.1 |
C19orf26
|
chromosome 19 open reading frame 26 |
| chr16_+_77822427 | 6.40 |
ENST00000302536.2
|
VAT1L
|
vesicle amine transport 1-like |
| chr10_-_7708918 | 6.39 |
ENST00000256861.6
ENST00000397146.2 ENST00000446830.2 ENST00000397145.2 |
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
| chr9_-_94712434 | 6.39 |
ENST00000375708.3
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2 |
| chr4_+_187065978 | 6.38 |
ENST00000227065.4
ENST00000502970.1 ENST00000514153.1 |
FAM149A
|
family with sequence similarity 149, member A |
| chr17_+_42836521 | 6.37 |
ENST00000535346.1
|
ADAM11
|
ADAM metallopeptidase domain 11 |
| chrX_+_149531524 | 6.34 |
ENST00000370401.2
|
MAMLD1
|
mastermind-like domain containing 1 |
| chr2_+_39893043 | 6.33 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
| chr16_+_222846 | 6.32 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr9_-_13279563 | 6.30 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
| chr16_+_25703274 | 6.29 |
ENST00000331351.5
|
HS3ST4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
| chr17_-_74533963 | 6.29 |
ENST00000293230.5
|
CYGB
|
cytoglobin |
| chr9_+_140772226 | 6.28 |
ENST00000277551.2
ENST00000371372.1 ENST00000277549.5 ENST00000371363.1 ENST00000371357.1 ENST00000371355.4 |
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
| chr19_-_47975417 | 6.26 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr15_-_79103757 | 6.25 |
ENST00000388820.4
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
| chr17_+_37783197 | 6.23 |
ENST00000582680.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr17_+_31254892 | 6.20 |
ENST00000394642.3
ENST00000579849.1 |
TMEM98
|
transmembrane protein 98 |
| chr17_+_31255165 | 6.20 |
ENST00000578289.1
ENST00000439138.1 |
TMEM98
|
transmembrane protein 98 |
| chr19_-_51054299 | 6.17 |
ENST00000599957.1
|
LRRC4B
|
leucine rich repeat containing 4B |
| chr17_-_41910505 | 6.17 |
ENST00000398389.4
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
| chrX_+_152760397 | 6.16 |
ENST00000331595.4
ENST00000431891.1 |
BGN
|
biglycan |
| chr11_-_119293903 | 6.14 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
| chr6_-_110500826 | 6.14 |
ENST00000265601.3
ENST00000447287.1 ENST00000444391.1 |
WASF1
|
WAS protein family, member 1 |
| chr6_-_35464817 | 6.12 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr20_-_41818536 | 6.12 |
ENST00000373193.3
ENST00000373198.4 ENST00000373201.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
| chr1_+_15250596 | 6.10 |
ENST00000361144.5
|
KAZN
|
kazrin, periplakin interacting protein |
| chr6_+_17393888 | 6.08 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr16_+_89894875 | 6.08 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
| chr15_-_71146480 | 6.08 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr17_-_31404 | 6.07 |
ENST00000343572.7
|
DOC2B
|
double C2-like domains, beta |
| chr7_-_82073031 | 6.07 |
ENST00000356253.5
ENST00000423588.1 |
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr12_-_50297638 | 6.02 |
ENST00000320634.3
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
| chr12_+_51984657 | 6.02 |
ENST00000550891.1
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
| chr17_+_8924837 | 6.02 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
| chr7_-_82073109 | 6.00 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr17_+_31255023 | 6.00 |
ENST00000395149.2
ENST00000261713.4 |
TMEM98
|
transmembrane protein 98 |
| chr19_+_3224700 | 5.99 |
ENST00000292672.2
ENST00000541430.2 |
CELF5
|
CUGBP, Elav-like family member 5 |
| chr14_+_94640633 | 5.98 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr8_-_133493200 | 5.94 |
ENST00000388996.4
|
KCNQ3
|
potassium voltage-gated channel, KQT-like subfamily, member 3 |
| chrX_+_38420623 | 5.92 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr7_+_75911902 | 5.92 |
ENST00000413003.1
|
SRRM3
|
serine/arginine repetitive matrix 3 |
| chr22_-_44258360 | 5.91 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr19_-_291133 | 5.90 |
ENST00000327790.3
|
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr15_+_80987617 | 5.89 |
ENST00000258884.4
ENST00000558464.1 |
ABHD17C
|
abhydrolase domain containing 17C |
| chr21_+_47401650 | 5.89 |
ENST00000361866.3
|
COL6A1
|
collagen, type VI, alpha 1 |
| chr16_+_86544113 | 5.85 |
ENST00000262426.4
|
FOXF1
|
forkhead box F1 |
| chr14_+_29236269 | 5.84 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr1_-_22263790 | 5.81 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr9_+_139873264 | 5.80 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr17_+_73717516 | 5.78 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
| chr2_-_110371664 | 5.78 |
ENST00000545389.1
ENST00000423520.1 |
SEPT10
|
septin 10 |
| chr11_+_101981169 | 5.77 |
ENST00000526343.1
ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1
|
Yes-associated protein 1 |
| chr19_+_45409011 | 5.77 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr11_+_43964055 | 5.76 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
| chr20_-_62130474 | 5.76 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr11_+_8040739 | 5.76 |
ENST00000534099.1
|
TUB
|
tubby bipartite transcription factor |
| chr14_+_100259666 | 5.74 |
ENST00000262233.6
ENST00000334192.4 |
EML1
|
echinoderm microtubule associated protein like 1 |
| chr5_+_9546306 | 5.74 |
ENST00000508179.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr9_+_132427883 | 5.73 |
ENST00000372469.4
|
PRRX2
|
paired related homeobox 2 |
| chr12_+_121078355 | 5.73 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
| chr7_-_45128472 | 5.71 |
ENST00000490531.2
|
NACAD
|
NAC alpha domain containing |
| chr20_+_1206679 | 5.71 |
ENST00000402452.1
ENST00000409241.1 ENST00000381882.2 ENST00000246108.3 |
RAD21L1
|
RAD21-like 1 (S. pombe) |
Network of associatons between targets according to the STRING database.
First level regulatory network of WT1_MTF1_ZBTB7B
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.1 | 48.9 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 5.6 | 16.7 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 4.5 | 31.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 4.0 | 16.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 4.0 | 16.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 3.8 | 11.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 3.7 | 22.0 | GO:0030421 | defecation(GO:0030421) |
| 3.6 | 10.9 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 3.6 | 3.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 3.5 | 14.0 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 3.5 | 10.4 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 3.4 | 13.4 | GO:1905069 | allantois development(GO:1905069) |
| 3.3 | 13.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 3.2 | 6.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 3.1 | 34.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 3.1 | 27.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 3.0 | 18.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 3.0 | 9.1 | GO:0060596 | mammary placode formation(GO:0060596) |
| 3.0 | 6.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 3.0 | 6.0 | GO:0060214 | endocardium formation(GO:0060214) |
| 2.9 | 14.6 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
| 2.9 | 11.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 2.9 | 8.7 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 2.7 | 8.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 2.7 | 13.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.7 | 35.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.6 | 7.9 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 2.6 | 2.6 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 2.6 | 7.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.6 | 10.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.5 | 22.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 2.5 | 7.5 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 2.5 | 2.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 2.4 | 7.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 2.4 | 11.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 2.4 | 7.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 2.4 | 11.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 2.3 | 4.6 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 2.3 | 16.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 2.3 | 6.9 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 2.3 | 4.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 2.3 | 6.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 2.3 | 18.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 2.2 | 6.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 2.2 | 2.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 2.2 | 11.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 2.2 | 15.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 2.2 | 13.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 2.2 | 4.4 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 2.1 | 8.4 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 2.1 | 8.3 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 2.0 | 12.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 2.0 | 18.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 2.0 | 2.0 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 2.0 | 4.0 | GO:0060594 | mammary gland specification(GO:0060594) |
| 2.0 | 23.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 2.0 | 4.0 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 1.9 | 5.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.9 | 27.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.9 | 9.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.9 | 5.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 1.9 | 15.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 1.9 | 3.8 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 1.9 | 9.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 1.9 | 11.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 1.9 | 5.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 1.9 | 9.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 1.9 | 5.6 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 1.9 | 11.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.9 | 9.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 1.9 | 9.3 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) epinephrine secretion(GO:0048242) |
| 1.9 | 5.6 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.9 | 7.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 1.8 | 7.4 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 1.8 | 16.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.8 | 38.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 1.8 | 3.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 1.8 | 7.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.8 | 15.9 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 1.8 | 5.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 1.8 | 35.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.7 | 12.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 1.7 | 19.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.7 | 8.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.7 | 5.2 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 1.7 | 8.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.7 | 5.2 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.7 | 5.1 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 1.7 | 5.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.7 | 5.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.7 | 18.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.7 | 13.5 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 1.7 | 16.9 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 1.7 | 1.7 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 1.7 | 1.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 1.7 | 5.0 | GO:0050894 | determination of affect(GO:0050894) |
| 1.6 | 6.6 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 1.6 | 4.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 1.6 | 19.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 1.6 | 6.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 1.6 | 3.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.6 | 1.6 | GO:0003193 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 1.6 | 3.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 1.6 | 11.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 1.6 | 8.1 | GO:0048749 | compound eye development(GO:0048749) |
| 1.6 | 1.6 | GO:0042637 | catagen(GO:0042637) regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
| 1.6 | 1.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 1.6 | 1.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.6 | 6.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.6 | 3.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.6 | 6.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 1.5 | 9.2 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.5 | 6.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.5 | 1.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 1.5 | 4.5 | GO:1903947 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 1.5 | 7.4 | GO:0030070 | insulin processing(GO:0030070) |
| 1.5 | 17.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 1.5 | 10.4 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.5 | 4.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.5 | 10.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 1.5 | 4.4 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 1.5 | 24.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.5 | 2.9 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.5 | 4.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.5 | 5.8 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 1.5 | 4.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.4 | 10.1 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 1.4 | 4.3 | GO:0048627 | myoblast development(GO:0048627) |
| 1.4 | 1.4 | GO:0021854 | hypothalamus development(GO:0021854) |
| 1.4 | 4.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 1.4 | 5.7 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.4 | 7.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 1.4 | 5.6 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 1.4 | 1.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.4 | 13.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.4 | 4.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.4 | 2.7 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.3 | 4.0 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 1.3 | 9.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 1.3 | 6.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.3 | 5.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.3 | 6.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 1.3 | 6.6 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.3 | 15.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.3 | 4.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 1.3 | 5.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.3 | 5.2 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.3 | 1.3 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
| 1.3 | 1.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 1.3 | 16.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 1.3 | 3.9 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
| 1.3 | 1.3 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 1.3 | 1.3 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 1.3 | 7.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.3 | 17.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 1.3 | 3.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.3 | 1.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 1.3 | 15.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 1.3 | 11.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 1.2 | 3.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 1.2 | 2.5 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 1.2 | 4.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.2 | 1.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 1.2 | 3.6 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 1.2 | 3.6 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.2 | 12.0 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.2 | 9.6 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
| 1.2 | 1.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.2 | 2.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.2 | 3.5 | GO:0033058 | directional locomotion(GO:0033058) |
| 1.2 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.2 | 9.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.2 | 4.6 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.1 | 4.6 | GO:0060306 | regulation of membrane repolarization(GO:0060306) regulation of membrane repolarization during action potential(GO:0098903) |
| 1.1 | 5.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.1 | 12.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 1.1 | 3.4 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.1 | 4.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 1.1 | 13.6 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 1.1 | 3.4 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.1 | 5.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.1 | 12.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.1 | 9.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 1.1 | 11.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.1 | 7.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 1.1 | 15.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 1.1 | 3.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 1.1 | 9.8 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.1 | 2.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.1 | 5.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 1.1 | 17.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.1 | 9.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.1 | 9.7 | GO:0046958 | nonassociative learning(GO:0046958) |
| 1.1 | 1.1 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
| 1.1 | 3.2 | GO:1904170 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 1.1 | 5.4 | GO:0001757 | somite specification(GO:0001757) |
| 1.1 | 2.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 1.1 | 8.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.1 | 2.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 1.1 | 3.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 1.1 | 1.1 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 1.1 | 4.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 1.1 | 10.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.1 | 10.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.0 | 1.0 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 1.0 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.0 | 7.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.0 | 18.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 1.0 | 2.1 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.0 | 5.2 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.0 | 18.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.0 | 2.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 1.0 | 15.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 1.0 | 6.1 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.0 | 5.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.0 | 5.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.0 | 13.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.0 | 10.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 1.0 | 3.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 1.0 | 10.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 1.0 | 6.0 | GO:0032341 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
| 1.0 | 3.0 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 1.0 | 9.0 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 1.0 | 1.0 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.0 | 4.9 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.0 | 4.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.0 | 4.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.0 | 2.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 1.0 | 1.0 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 1.0 | 10.7 | GO:0051610 | serotonin uptake(GO:0051610) |
| 1.0 | 8.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 1.0 | 2.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 1.0 | 4.8 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.0 | 8.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 1.0 | 3.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.0 | 49.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.9 | 4.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.9 | 4.7 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.9 | 2.8 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.9 | 1.9 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.9 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 | 15.9 | GO:0035878 | nail development(GO:0035878) |
| 0.9 | 5.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.9 | 3.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.9 | 1.9 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.9 | 1.8 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.9 | 13.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.9 | 5.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.9 | 3.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 | 0.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.9 | 9.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.9 | 51.3 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.9 | 3.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.9 | 3.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.9 | 5.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.9 | 1.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.9 | 1.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.9 | 6.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.9 | 5.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.9 | 2.7 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.9 | 1.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.9 | 6.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.9 | 3.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.9 | 21.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.9 | 4.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.9 | 5.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.9 | 7.9 | GO:0003383 | apical constriction(GO:0003383) |
| 0.9 | 8.7 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.9 | 9.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.9 | 3.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.9 | 15.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.9 | 3.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.9 | 2.6 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.9 | 4.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.9 | 1.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.8 | 2.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.8 | 36.5 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.8 | 2.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.8 | 2.5 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.8 | 5.8 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.8 | 2.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.8 | 1.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.8 | 5.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.8 | 2.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.8 | 3.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.8 | 0.8 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.8 | 3.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.8 | 3.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.8 | 4.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.8 | 6.3 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.8 | 2.4 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.8 | 2.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.8 | 3.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.8 | 4.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.8 | 15.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.8 | 9.4 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.8 | 1.6 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) negative regulation of gastrulation(GO:2000542) |
| 0.8 | 2.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.8 | 2.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.8 | 10.9 | GO:0060068 | vagina development(GO:0060068) |
| 0.8 | 2.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.8 | 6.1 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.8 | 0.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.8 | 3.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.8 | 3.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 3.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.8 | 1.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.8 | 2.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.8 | 3.0 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.7 | 0.7 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.7 | 0.7 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.7 | 2.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.7 | 8.1 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.7 | 0.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 | 21.9 | GO:0033622 | integrin activation(GO:0033622) |
| 0.7 | 2.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.7 | 0.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.7 | 4.3 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.7 | 2.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.7 | 1.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 | 2.2 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.7 | 2.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.7 | 2.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
| 0.7 | 7.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.7 | 4.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.7 | 5.0 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.7 | 7.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.7 | 19.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.7 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.7 | 9.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.7 | 2.8 | GO:0021794 | thalamus development(GO:0021794) |
| 0.7 | 11.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.7 | 2.8 | GO:0042335 | cuticle development(GO:0042335) |
| 0.7 | 7.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.7 | 0.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.7 | 2.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.7 | 4.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 | 0.7 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.7 | 4.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.7 | 15.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.7 | 14.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.7 | 1.4 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.7 | 1.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.7 | 2.7 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.7 | 4.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 | 16.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.7 | 1.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.7 | 2.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.7 | 2.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.7 | 0.7 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.7 | 17.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.7 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.7 | 5.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.7 | 2.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.7 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.7 | 3.3 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.7 | 6.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.7 | 1.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.7 | 2.0 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.7 | 0.7 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.7 | 6.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.7 | 5.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.7 | 8.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.7 | 5.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.7 | 3.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.7 | 3.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.6 | 1.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.6 | 0.6 | GO:0072033 | renal vesicle formation(GO:0072033) |
| 0.6 | 6.4 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.6 | 1.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.6 | 3.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.6 | 1.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.6 | 1.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.6 | 10.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.6 | 3.8 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.6 | 3.8 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.6 | 4.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 | 48.6 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
| 0.6 | 3.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.6 | 6.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.6 | 5.0 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.6 | 0.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.6 | 5.0 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.6 | 11.1 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.6 | 2.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.6 | 7.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 1.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.6 | 1.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.6 | 7.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.6 | 6.0 | GO:0015820 | leucine transport(GO:0015820) |
| 0.6 | 9.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.6 | 1.8 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.6 | 3.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.6 | 10.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.6 | 6.5 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.6 | 4.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.6 | 6.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.6 | 1.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.6 | 1.2 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.6 | 1.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.6 | 1.2 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.6 | 1.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 | 0.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.6 | 6.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.6 | 1.7 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.6 | 2.9 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.6 | 12.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.6 | 2.8 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.6 | 2.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.6 | 1.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.6 | 14.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.6 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.6 | 0.6 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.6 | 1.7 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
| 0.6 | 2.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.6 | 1.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.6 | 6.1 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.6 | 6.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.6 | 6.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.6 | 3.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.6 | 2.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.6 | 4.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.6 | 2.8 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.5 | 8.7 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.5 | 9.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.5 | 4.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.5 | 4.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.5 | 6.4 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.5 | 9.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.5 | 1.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 | 1.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.5 | 3.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.5 | 2.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.5 | 1.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.5 | 2.1 | GO:1990834 | response to odorant(GO:1990834) |
| 0.5 | 3.2 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.5 | 1.6 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.5 | 3.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.5 | 2.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.5 | 1.6 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
| 0.5 | 11.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.5 | 0.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.5 | 3.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.5 | 1.5 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.5 | 0.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.5 | 3.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.5 | 0.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.5 | 5.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.5 | 6.6 | GO:1903275 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.5 | 2.0 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.5 | 2.5 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.5 | 9.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.5 | 3.0 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.5 | 1.0 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.5 | 10.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.5 | 2.5 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 | 13.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.5 | 1.5 | GO:0046056 | dADP biosynthetic process(GO:0006173) dADP metabolic process(GO:0046056) |
| 0.5 | 10.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.5 | 10.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.5 | 1.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.5 | 2.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.5 | 2.0 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.5 | 30.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.5 | 2.9 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.5 | 7.9 | GO:0043090 | amino acid import(GO:0043090) |
| 0.5 | 1.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 | 13.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.5 | 4.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.5 | 5.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.5 | 7.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.5 | 9.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.5 | 4.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.5 | 11.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.5 | 1.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.5 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.5 | 9.5 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.5 | 2.8 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 0.5 | 2.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 14.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
| 0.5 | 0.9 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.5 | 1.4 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.5 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.5 | 1.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 0.5 | 0.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.5 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.5 | 4.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 | 1.9 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.5 | 3.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 1.4 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.5 | 0.5 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.5 | 2.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.5 | 22.9 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
| 0.5 | 5.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.5 | 0.5 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
| 0.5 | 12.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.5 | 5.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.5 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.5 | 2.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.4 | 1.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 | 4.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.4 | 1.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.4 | 8.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
| 0.4 | 1.3 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.4 | 1.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 0.4 | 1.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 2.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 6.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.4 | 17.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.4 | 1.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.4 | 4.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 | 4.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 1.8 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.4 | 1.3 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.4 | 6.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 2.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.4 | 8.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 0.4 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.4 | 0.9 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.4 | 2.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 | 0.9 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 | 2.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.4 | 3.5 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.4 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.4 | 3.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
| 0.4 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.4 | 12.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.4 | 7.8 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
| 0.4 | 10.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.4 | 7.3 | GO:0048265 | response to pain(GO:0048265) |
| 0.4 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.4 | 2.1 | GO:0050893 | sensory processing(GO:0050893) |
| 0.4 | 4.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.4 | 2.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.4 | 1.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.4 | 4.7 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.4 | 1.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 | 1.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.4 | 0.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.4 | 0.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.4 | 1.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.4 | 2.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.4 | 1.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 | 1.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.4 | 5.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 7.4 | GO:0009650 | UV protection(GO:0009650) |
| 0.4 | 2.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.4 | 2.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.4 | 6.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.4 | 2.0 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.4 | 2.8 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 | 4.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.4 | 3.2 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.4 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.4 | 2.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 | 2.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.4 | 1.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.4 | 1.6 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.4 | 15.6 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.4 | 3.6 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.4 | 0.8 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.4 | 0.8 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.4 | 0.8 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
| 0.4 | 3.6 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.4 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.4 | 5.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.4 | 2.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.4 | 28.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.4 | 2.0 | GO:2000170 | negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.4 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.4 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.4 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.4 | 2.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.4 | 1.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.4 | 1.2 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.4 | 0.4 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.4 | 1.6 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 2.3 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 | 1.2 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.4 | 0.4 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.4 | 8.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.4 | 1.9 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.4 | 4.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.4 | 1.5 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 | 3.8 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.4 | 0.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.4 | 1.1 | GO:0018963 | insecticide metabolic process(GO:0017143) phthalate metabolic process(GO:0018963) |
| 0.4 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.4 | 0.4 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.4 | 1.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.4 | 5.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.4 | 4.1 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.4 | 2.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.4 | 1.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.4 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 | 3.0 | GO:0097205 | renal filtration(GO:0097205) |
| 0.4 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.4 | 3.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.4 | 1.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.4 | 1.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.4 | 1.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.4 | 10.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.4 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.4 | 1.1 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.4 | 16.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.4 | 1.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.4 | 3.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.4 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 1.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.4 | 2.9 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.4 | 8.2 | GO:0051937 | catecholamine transport(GO:0051937) |
| 0.4 | 1.4 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.4 | 1.1 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.4 | 0.7 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
| 0.4 | 0.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.4 | 2.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.4 | 2.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.4 | 1.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.4 | 2.1 | GO:0061055 | myotome development(GO:0061055) |
| 0.3 | 1.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.3 | 1.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.3 | 3.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
| 0.3 | 6.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 | 38.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.3 | 1.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.3 | 3.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.3 | 12.1 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.3 | 1.7 | GO:0035864 | response to potassium ion(GO:0035864) |
| 0.3 | 0.3 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 | 3.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 | 6.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 | 34.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.3 | 0.7 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.3 | 1.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.3 | 6.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.3 | 2.6 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
| 0.3 | 1.0 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 | 9.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) positive regulation of oocyte maturation(GO:1900195) |
| 0.3 | 9.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.3 | 1.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.3 | 14.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.3 | 2.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.3 | 3.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.3 | 11.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.3 | 1.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.3 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.3 | 5.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 | 16.3 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.3 | 2.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.3 | 57.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.3 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.3 | 1.0 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.3 | 2.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
| 0.3 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.3 | 0.9 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 | 5.0 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.3 | 0.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.3 | 0.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.3 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.3 | 5.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.3 | 0.6 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.3 | 2.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 2.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 | 4.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 | 0.9 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.3 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 28.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.3 | 2.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.3 | 2.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.3 | 0.9 | GO:0060841 | venous blood vessel development(GO:0060841) |
| 0.3 | 2.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.3 | 0.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.3 | 0.3 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
| 0.3 | 0.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.3 | 0.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 0.6 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.3 | 4.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.3 | 2.9 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.3 | 1.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.3 | 11.1 | GO:0003341 | cilium movement(GO:0003341) |
| 0.3 | 0.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.3 | 0.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.3 | 9.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.3 | 6.7 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 | 6.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.3 | 2.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.3 | 3.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 4.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 4.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 1.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 | 0.5 | GO:0045685 | regulation of glial cell differentiation(GO:0045685) |
| 0.3 | 2.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 | 1.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.3 | 3.2 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.3 | 1.3 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.3 | 1.9 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.3 | 0.8 | GO:0051685 | endoplasmic reticulum localization(GO:0051643) maintenance of ER location(GO:0051685) |
| 0.3 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) penile erection(GO:0043084) |
| 0.3 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.3 | 4.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.3 | 1.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 0.8 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 1.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.3 | 0.3 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.3 | 1.6 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.3 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 | 0.3 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.3 | 1.0 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.3 | 3.9 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.3 | 2.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.3 | 4.1 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.3 | 3.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.3 | 0.8 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.3 | 1.8 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.3 | 0.8 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.3 | 7.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.3 | 1.5 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.3 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 1.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.3 | 6.1 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.3 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
| 0.3 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.3 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.3 | 0.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.2 | 1.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 3.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 1.7 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 5.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 1.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 5.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.2 | 1.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.2 | 6.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.2 | 0.2 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.2 | 3.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 1.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 | 1.4 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 | 1.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.2 | 0.2 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.2 | 1.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 | 2.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 1.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 0.5 | GO:0034698 | response to gonadotropin(GO:0034698) |
| 0.2 | 5.6 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.2 | 0.7 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.2 | 1.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.2 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.2 | 10.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.2 | 5.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 0.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 | 1.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 | 9.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 | 13.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 26.6 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 6.5 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 0.2 | 1.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.2 | 3.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 2.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 0.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.2 | 3.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.2 | 2.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.2 | 0.7 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.2 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.2 | 3.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 0.4 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 | 1.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.2 | 1.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.4 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.2 | 4.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.2 | 1.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 | 9.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 0.6 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.2 | 0.2 | GO:0071048 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.2 | 1.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.2 | 0.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 4.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.2 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
| 0.2 | 0.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.2 | 6.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.2 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.2 | 0.6 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.2 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
| 0.2 | 0.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.2 | 1.7 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.2 | 1.9 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.2 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 1.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 | 4.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 2.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 | 0.2 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
| 0.2 | 19.8 | GO:0001764 | neuron migration(GO:0001764) |
| 0.2 | 3.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.2 | 0.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.2 | 4.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.2 | 6.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.2 | 1.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.2 | 2.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.2 | 0.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.2 | 0.8 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.2 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.2 | 17.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 1.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 | 8.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.2 | 5.6 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.2 | 4.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 | 2.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.2 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.2 | 0.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 0.2 | 1.7 | GO:0031016 | pancreas development(GO:0031016) |
| 0.2 | 1.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 0.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
| 0.2 | 0.4 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 0.6 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.2 | 5.3 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 | 2.4 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 6.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.2 | 0.9 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 0.2 | 6.0 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
| 0.2 | 31.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 | 3.9 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.2 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 1.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.2 | 1.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 | 0.5 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 0.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.2 | 6.1 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.2 | 3.9 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.2 | 2.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 1.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.2 | 1.9 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.2 | 1.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 0.9 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.2 | 0.9 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.2 | 1.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.2 | 2.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 | 4.2 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 1.7 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.2 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 | 2.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.2 | 1.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 | 2.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.7 | GO:0034371 | chylomicron remodeling(GO:0034371) |
| 0.2 | 2.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 0.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.2 | 1.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 0.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.2 | 1.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) negative regulation of vasoconstriction(GO:0045906) negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 | 0.5 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 2.4 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.2 | 8.0 | GO:0007129 | synapsis(GO:0007129) |
| 0.2 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.2 | 2.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 | 3.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 1.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 | 0.3 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.2 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 1.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 0.3 | GO:0007127 | meiosis I(GO:0007127) |
| 0.2 | 0.8 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.2 | 1.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 0.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 1.9 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.2 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 1.4 | GO:0007350 | blastoderm segmentation(GO:0007350) |
| 0.2 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 1.4 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
| 0.2 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 | 2.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 1.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 | 2.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.1 | 0.7 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
| 0.1 | 1.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 | 1.0 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 | 0.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.6 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
| 0.1 | 1.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 0.6 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 0.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 | 0.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.1 | 11.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.1 | 0.1 | GO:0044848 | biological phase(GO:0044848) |
| 0.1 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 1.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 3.5 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.1 | 0.3 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.4 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 | 1.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.1 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.1 | 1.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.1 | 2.7 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.4 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
| 0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.1 | 0.9 | GO:0044650 | adhesion of symbiont to host cell(GO:0044650) |
| 0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 2.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 | 1.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 | 0.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 | 2.5 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 | 2.1 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.1 | 1.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
| 0.1 | 0.3 | GO:0003207 | cardiac chamber formation(GO:0003207) |
| 0.1 | 1.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 0.1 | 0.6 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.1 | 1.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.9 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 1.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 3.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 5.2 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
| 0.1 | 0.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 1.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.1 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 2.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 1.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 1.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 | 1.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 | 0.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 0.3 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 | 1.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 2.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.1 | 0.6 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.1 | 0.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.1 | 1.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 1.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.4 | GO:0071599 | otic vesicle development(GO:0071599) |
| 0.1 | 1.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.1 | 0.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.1 | 1.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 0.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.1 | 1.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) nucleobase catabolic process(GO:0046113) |
| 0.1 | 0.8 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.6 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
| 0.1 | 0.3 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.1 | 0.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.9 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 | 1.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 11.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.3 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.1 | 2.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.7 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.1 | 2.4 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
| 0.1 | 1.6 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
| 0.1 | 0.1 | GO:0042551 | neuron maturation(GO:0042551) |
| 0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 | 0.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.1 | 0.6 | GO:0009415 | response to water(GO:0009415) |
| 0.1 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 | 0.3 | GO:0042698 | ovulation cycle(GO:0042698) |
| 0.1 | 2.8 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.3 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 0.4 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 1.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.4 | GO:0006522 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 0.1 | 0.4 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.1 | 1.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.1 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 | 0.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 | 1.4 | GO:0017157 | regulation of exocytosis(GO:0017157) |
| 0.1 | 0.9 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 | 0.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.3 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 | 0.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 | 1.1 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 0.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 1.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 1.9 | GO:0007602 | phototransduction(GO:0007602) |
| 0.1 | 0.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.3 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.1 | 0.1 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.1 | 1.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
| 0.1 | 0.9 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 | 3.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.2 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.1 | 1.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 0.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.1 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.1 | 0.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 0.8 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.1 | 0.5 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 1.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.1 | 0.1 | GO:0003014 | renal system process(GO:0003014) |
| 0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.1 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
| 0.1 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 0.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.1 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
| 0.1 | 0.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.7 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.1 | 1.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.1 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.5 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 2.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 5.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.1 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.1 | 0.3 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
| 0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.1 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.8 | GO:0048675 | axon extension(GO:0048675) |
| 0.1 | 0.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 | 2.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.1 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.1 | 0.4 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.2 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 | 0.2 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 | 1.3 | GO:0008542 | visual learning(GO:0008542) |
| 0.1 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.2 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.2 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.3 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.1 | 0.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.1 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 | 2.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.1 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.1 | 0.2 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 1.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.0 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 | 1.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 0.2 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 | 0.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.0 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 | 0.8 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
| 0.0 | 0.1 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.5 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
| 0.0 | 0.8 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.0 | 0.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.5 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.0 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 | 0.0 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.0 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.1 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
| 0.0 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.0 | 1.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.6 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.0 | 0.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.0 | 0.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.5 | GO:0090266 | regulation of spindle checkpoint(GO:0090231) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.9 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 | 0.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 | 0.0 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 | 0.4 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
| 0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
| 0.0 | 0.2 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 2.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.0 | 0.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.3 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
| 0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.0 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 2.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.0 | 0.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.0 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.0 | 2.5 | GO:0007626 | locomotory behavior(GO:0007626) |
| 0.0 | 7.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 1.2 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.0 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.0 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 0.8 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.0 | 0.1 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
| 0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 | 0.8 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
| 0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 | 0.2 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.1 | GO:0042445 | hormone metabolic process(GO:0042445) |
| 0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.0 | GO:0015677 | copper ion import(GO:0015677) |
| 0.0 | 0.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 | 0.0 | GO:0010193 | response to ozone(GO:0010193) |
| 0.0 | 0.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 | 0.1 | GO:0070189 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
| 0.0 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.0 | 0.0 | GO:0045924 | regulation of female receptivity(GO:0045924) |
| 0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 | 0.5 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 | 0.0 | GO:0098868 | bone growth(GO:0098868) |
| 0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 | 0.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
| 0.0 | 0.0 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 | 0.1 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 0.0 | 0.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 0.0 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 | 0.0 | GO:0071871 | response to epinephrine(GO:0071871) |
| 0.0 | 0.2 | GO:0046755 | viral budding via host ESCRT complex(GO:0039702) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
| 0.0 | 0.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.0 | 0.0 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.9 | 55.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 3.6 | 10.8 | GO:0098855 | HCN channel complex(GO:0098855) |
| 3.4 | 17.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 3.2 | 9.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 3.1 | 18.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 2.9 | 8.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 2.8 | 11.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 2.8 | 8.4 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 2.7 | 13.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 2.6 | 10.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.6 | 49.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 2.6 | 5.2 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 2.6 | 12.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 2.2 | 6.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 2.2 | 13.2 | GO:0097513 | myosin II filament(GO:0097513) |
| 2.2 | 11.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 2.1 | 2.1 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 2.0 | 34.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 1.9 | 5.8 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 1.8 | 7.3 | GO:0060187 | cell pole(GO:0060187) |
| 1.8 | 19.9 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.8 | 5.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.7 | 3.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.7 | 14.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.6 | 29.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 1.6 | 4.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 1.6 | 6.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.6 | 49.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 1.5 | 20.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.5 | 12.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.5 | 1.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 1.4 | 35.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.4 | 8.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 1.3 | 3.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.3 | 3.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.2 | 48.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 1.2 | 16.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 1.2 | 6.0 | GO:0016938 | kinesin I complex(GO:0016938) |
| 1.2 | 6.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.2 | 7.2 | GO:0031673 | H zone(GO:0031673) |
| 1.2 | 1.2 | GO:0044301 | climbing fiber(GO:0044301) |
| 1.1 | 3.4 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 1.1 | 6.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 1.1 | 25.6 | GO:0032590 | dendrite membrane(GO:0032590) |
| 1.1 | 2.2 | GO:0005683 | U7 snRNP(GO:0005683) |
| 1.1 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.1 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.1 | 4.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 1.1 | 13.7 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.1 | 4.2 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.0 | 6.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 1.0 | 5.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 1.0 | 7.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.0 | 6.2 | GO:1990742 | microvesicle(GO:1990742) |
| 1.0 | 6.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.0 | 8.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 1.0 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
| 1.0 | 3.0 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 1.0 | 4.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.0 | 44.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 1.0 | 5.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.9 | 2.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.9 | 7.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.9 | 11.1 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.9 | 21.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.9 | 2.7 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.9 | 8.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.9 | 47.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.9 | 4.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.8 | 36.3 | GO:0005921 | gap junction(GO:0005921) |
| 0.8 | 1.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.8 | 2.5 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.8 | 10.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.8 | 5.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.8 | 5.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.8 | 27.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.8 | 5.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.8 | 6.0 | GO:0043218 | compact myelin(GO:0043218) |
| 0.7 | 3.0 | GO:0030849 | autosome(GO:0030849) |
| 0.7 | 1.5 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.7 | 8.0 | GO:0005883 | neurofilament(GO:0005883) |
| 0.7 | 2.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.7 | 4.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.7 | 1.4 | GO:1990923 | PET complex(GO:1990923) |
| 0.7 | 15.8 | GO:0031045 | dense core granule(GO:0031045) |
| 0.7 | 8.9 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.7 | 7.5 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.7 | 12.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.7 | 27.5 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.7 | 0.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.7 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.7 | 9.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.6 | 96.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.6 | 1.9 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.6 | 1.9 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.6 | 3.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.6 | 25.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.6 | 2.4 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.6 | 12.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.6 | 3.0 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.6 | 10.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.6 | 1.8 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.6 | 2.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.6 | 8.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.6 | 9.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.6 | 1.7 | GO:0001534 | radial spoke(GO:0001534) |
| 0.6 | 4.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 49.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.6 | 21.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.6 | 7.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.6 | 16.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.6 | 6.2 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.6 | 10.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.6 | 1.7 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.6 | 78.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.5 | 54.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.5 | 3.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.5 | 1.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.5 | 10.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.5 | 12.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.5 | 0.5 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.5 | 3.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.5 | 11.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.5 | 29.8 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.5 | 6.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.5 | 73.7 | GO:0043204 | perikaryon(GO:0043204) |
| 0.5 | 2.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.5 | 2.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.5 | 6.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.5 | 6.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.5 | 1.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.5 | 1.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.5 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.5 | 6.2 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.5 | 2.8 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.5 | 2.3 | GO:0070701 | mucus layer(GO:0070701) |
| 0.5 | 52.2 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.5 | 1.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.5 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.5 | 3.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.5 | 10.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.5 | 0.9 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.5 | 62.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.4 | 12.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 2.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.4 | 2.2 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.4 | 2.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 1.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.4 | 0.4 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.4 | 3.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.4 | 18.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.4 | 1.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.4 | 1.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.4 | 1.7 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.4 | 15.0 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.4 | 5.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 24.4 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.4 | 4.6 | GO:0097433 | dense body(GO:0097433) |
| 0.4 | 18.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.4 | 2.7 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.4 | 0.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.4 | 3.8 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 29.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.4 | 2.6 | GO:0045179 | apical cortex(GO:0045179) |
| 0.4 | 43.7 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.4 | 54.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.4 | 5.6 | GO:0008091 | spectrin(GO:0008091) |
| 0.4 | 19.3 | GO:0097546 | ciliary base(GO:0097546) |
| 0.4 | 17.4 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 5.2 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.4 | 4.8 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 25.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.4 | 63.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.3 | 3.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 8.2 | GO:0043034 | costamere(GO:0043034) |
| 0.3 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.3 | 0.3 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.3 | 1.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.3 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.3 | 1.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.3 | 3.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.3 | 9.9 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 2.3 | GO:0098536 | deuterosome(GO:0098536) |
| 0.3 | 84.0 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.3 | 105.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.3 | 5.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.3 | 2.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.3 | 0.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.3 | 1.6 | GO:0032449 | CBM complex(GO:0032449) |
| 0.3 | 3.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.3 | 1.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 33.9 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.3 | 19.7 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.3 | 70.0 | GO:0098793 | presynapse(GO:0098793) |
| 0.3 | 9.7 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.3 | 3.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 3.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.3 | 72.9 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.3 | 3.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.3 | 3.0 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.3 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
| 0.3 | 0.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 1.1 | GO:0000811 | GINS complex(GO:0000811) |
| 0.3 | 19.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.3 | 1.6 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.3 | 15.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.3 | 7.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.3 | 3.1 | GO:0032420 | stereocilium(GO:0032420) |
| 0.3 | 3.4 | GO:0033643 | host cell part(GO:0033643) |
| 0.3 | 1.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 5.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.3 | 6.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.3 | 1.0 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 0.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 1.7 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 3.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 1.7 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 1.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 69.0 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.2 | 9.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 6.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 13.3 | GO:0030286 | dynein complex(GO:0030286) |
| 0.2 | 3.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.2 | 2.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.2 | 11.8 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 3.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 1.8 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.2 | 14.8 | GO:0030426 | growth cone(GO:0030426) |
| 0.2 | 2.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.2 | 1.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 1.5 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.2 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.2 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 1.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 5.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 0.6 | GO:0044297 | cell body(GO:0044297) |
| 0.2 | 2.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.2 | 2.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.2 | 4.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 25.5 | GO:0030424 | axon(GO:0030424) |
| 0.2 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.2 | 0.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.2 | 5.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.2 | 3.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 9.4 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 1.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.2 | 2.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 2.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.2 | 13.8 | GO:0031514 | motile cilium(GO:0031514) |
| 0.2 | 1.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 0.7 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.1 | 2.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.1 | 4.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 19.8 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 7.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 1.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 2.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.1 | 25.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 2.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 1.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 15.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 4.9 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.1 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.3 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 3.7 | GO:0034703 | cation channel complex(GO:0034703) |
| 0.1 | 19.2 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 1.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 2.1 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 7.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 0.5 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 5.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 1.2 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 1.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.1 | 0.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 11.6 | GO:0005938 | cell cortex(GO:0005938) |
| 0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 1.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.1 | 0.3 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
| 0.1 | 3.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.3 | GO:0031213 | RSF complex(GO:0031213) |
| 0.1 | 6.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.1 | 6.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 110.6 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.1 | GO:0070160 | occluding junction(GO:0070160) |
| 0.1 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 5.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 0.1 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.0 | 0.0 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.0 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.0 | 3.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.0 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.0 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 2.8 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 5.7 | GO:0005929 | cilium(GO:0005929) |
| 0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 1.6 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 179.6 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 0.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 1.1 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.0 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.1 | GO:1990351 | transporter complex(GO:1990351) |
| 0.0 | 0.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.4 | 51.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 4.8 | 4.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 4.4 | 13.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 4.0 | 12.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 3.4 | 13.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 3.3 | 9.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 3.3 | 13.1 | GO:0016662 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 3.2 | 12.7 | GO:0035939 | microsatellite binding(GO:0035939) |
| 3.1 | 3.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 2.8 | 14.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 2.8 | 25.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 2.7 | 10.7 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 2.7 | 13.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 2.5 | 12.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 2.5 | 7.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 2.4 | 22.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 2.4 | 4.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 2.4 | 9.6 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 2.4 | 2.4 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 2.3 | 27.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 2.3 | 9.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 2.2 | 11.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 2.2 | 6.6 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 2.2 | 10.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 2.1 | 17.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 2.1 | 6.4 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 2.0 | 7.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 2.0 | 13.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 1.9 | 7.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.8 | 5.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 1.8 | 14.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 1.8 | 7.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 1.8 | 16.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 1.7 | 53.5 | GO:0031005 | filamin binding(GO:0031005) |
| 1.7 | 5.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 1.7 | 6.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 1.7 | 3.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 1.6 | 1.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 1.6 | 33.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 1.6 | 4.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 1.6 | 23.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.6 | 7.8 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 1.6 | 1.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 1.6 | 15.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.5 | 4.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.5 | 1.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.5 | 56.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 1.5 | 9.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 1.5 | 6.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.5 | 7.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 1.5 | 8.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.5 | 10.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 1.5 | 7.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 1.4 | 13.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 1.4 | 7.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 1.4 | 7.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 1.4 | 12.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.4 | 12.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 1.4 | 5.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.4 | 19.3 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.4 | 12.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 1.4 | 25.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.3 | 15.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 1.3 | 13.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.3 | 10.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 1.3 | 6.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.3 | 7.8 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 1.3 | 3.8 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 1.3 | 3.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.3 | 12.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.2 | 5.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 1.2 | 11.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.2 | 11.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 1.2 | 7.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 1.2 | 3.6 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 1.2 | 3.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 1.2 | 7.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.2 | 14.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 1.2 | 7.1 | GO:0097001 | ceramide binding(GO:0097001) |
| 1.2 | 10.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.2 | 48.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 1.2 | 5.8 | GO:0034584 | piRNA binding(GO:0034584) |
| 1.2 | 5.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.1 | 9.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.1 | 5.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.1 | 3.3 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 1.1 | 4.4 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.1 | 5.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 1.1 | 7.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 1.1 | 5.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 1.1 | 4.3 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 1.1 | 19.1 | GO:0015250 | water channel activity(GO:0015250) |
| 1.1 | 11.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 1.1 | 8.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.1 | 11.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 1.0 | 3.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 1.0 | 9.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.0 | 3.1 | GO:0005522 | profilin binding(GO:0005522) |
| 1.0 | 8.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 1.0 | 7.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.0 | 7.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 1.0 | 24.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 1.0 | 6.1 | GO:0052840 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 1.0 | 3.0 | GO:0030984 | kininogen binding(GO:0030984) |
| 1.0 | 9.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 1.0 | 10.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 1.0 | 23.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 1.0 | 2.9 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 1.0 | 11.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.0 | 5.8 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 1.0 | 6.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 1.0 | 4.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 1.0 | 26.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.9 | 16.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.9 | 3.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.9 | 7.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.9 | 5.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.9 | 2.7 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.9 | 2.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.9 | 20.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.9 | 5.4 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.9 | 2.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.9 | 12.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.9 | 2.7 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.9 | 16.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.9 | 3.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.9 | 14.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.9 | 2.6 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.9 | 2.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.9 | 2.6 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.9 | 17.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.8 | 4.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.8 | 5.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.8 | 4.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.8 | 7.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.8 | 3.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.8 | 3.2 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.8 | 4.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.8 | 2.4 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.8 | 19.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.8 | 18.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.8 | 6.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.8 | 3.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.8 | 3.1 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.8 | 2.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.8 | 3.0 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.8 | 11.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.8 | 4.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.8 | 30.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.7 | 10.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.7 | 10.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.7 | 2.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.7 | 5.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.7 | 5.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.7 | 7.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.7 | 12.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.7 | 5.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.7 | 6.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.7 | 2.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.7 | 5.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.7 | 2.9 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.7 | 5.0 | GO:0048185 | activin binding(GO:0048185) |
| 0.7 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.7 | 9.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.7 | 10.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.7 | 5.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.7 | 2.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.7 | 9.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.7 | 1.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.7 | 3.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.7 | 30.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.7 | 2.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.7 | 21.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.7 | 8.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.7 | 0.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.7 | 22.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.7 | 16.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.7 | 7.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.7 | 3.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.7 | 3.9 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.6 | 14.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.6 | 3.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.6 | 1.9 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.6 | 11.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.6 | 34.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.6 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
| 0.6 | 2.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.6 | 8.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.6 | 2.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.6 | 7.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.6 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.6 | 9.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.6 | 4.2 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.6 | 1.8 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.6 | 18.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.6 | 1.2 | GO:0004938 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
| 0.6 | 0.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.6 | 22.4 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.6 | 2.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.6 | 4.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.6 | 2.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.6 | 5.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.6 | 1.7 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.6 | 5.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.6 | 2.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.6 | 0.6 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.6 | 1.7 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.6 | 0.6 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.6 | 3.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.6 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.6 | 2.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.5 | 4.4 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.5 | 11.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.5 | 1.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.5 | 17.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.5 | 2.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.5 | 3.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.5 | 18.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.5 | 2.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.5 | 3.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.5 | 20.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.5 | 8.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.5 | 7.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.5 | 5.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.5 | 4.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.5 | 3.1 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.5 | 4.7 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.5 | 4.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.5 | 1.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.5 | 1.5 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.5 | 3.6 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.5 | 2.6 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.5 | 3.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.5 | 2.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.5 | 2.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.5 | 12.4 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.5 | 6.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.5 | 3.5 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.5 | 14.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.5 | 2.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.5 | 54.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.5 | 24.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.5 | 12.7 | GO:0016918 | retinal binding(GO:0016918) |
| 0.5 | 8.4 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.5 | 1.9 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.5 | 8.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.5 | 3.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.5 | 9.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.5 | 1.4 | GO:0005113 | patched binding(GO:0005113) |
| 0.4 | 3.6 | GO:0042805 | actinin binding(GO:0042805) |
| 0.4 | 4.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.4 | 1.3 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.4 | 8.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.4 | 6.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.4 | 0.9 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.4 | 50.8 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.4 | 11.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.4 | 1.3 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.4 | 0.4 | GO:0045502 | dynein binding(GO:0045502) |
| 0.4 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.4 | 4.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.4 | 2.6 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.4 | 18.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 2.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.4 | 5.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.4 | 1.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.4 | 2.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.4 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 0.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.4 | 1.2 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.4 | 0.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 53.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.4 | 4.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.4 | 11.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.4 | 2.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.4 | 2.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 9.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.4 | 1.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 3.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.4 | 2.0 | GO:0008430 | selenium binding(GO:0008430) |
| 0.4 | 14.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 2.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.4 | 1.2 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.4 | 0.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 40.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.4 | 1.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.4 | 1.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 20.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.4 | 1.5 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.4 | 3.4 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.4 | 2.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.4 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.4 | 5.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.4 | 23.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.4 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.4 | 1.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.4 | 3.6 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.4 | 16.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.4 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.4 | 1.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.4 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.3 | 5.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.3 | 4.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.3 | 10.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.3 | 3.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.3 | 4.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.3 | 2.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 2.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.3 | 3.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 2.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.3 | 3.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.3 | 2.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 3.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 4.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 2.3 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.3 | 1.0 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.3 | 1.0 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.3 | 2.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.3 | 1.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.3 | 2.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.3 | 7.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.3 | 7.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.3 | 7.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.3 | 0.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.3 | 9.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.3 | 3.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 0.9 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.3 | 17.2 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 5.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 7.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.3 | 2.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 9.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 0.3 | 4.6 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.3 | 2.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.3 | 0.9 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.3 | 29.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.3 | 4.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.3 | 5.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.3 | 3.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 12.6 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 4.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.3 | 2.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.3 | 10.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.3 | 8.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.3 | 5.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.3 | 0.9 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.3 | 1.5 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.3 | 3.5 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.3 | 2.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.3 | 10.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.3 | 0.9 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.3 | 3.8 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.3 | 2.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 8.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.3 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
| 0.3 | 2.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.3 | 2.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.3 | 4.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.3 | 6.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 1.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 0.8 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.3 | 2.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.3 | 4.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 3.6 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.3 | 4.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.3 | 22.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.3 | 1.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.3 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 1.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.3 | 0.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.3 | 4.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.3 | 2.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.3 | 10.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.3 | 1.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.3 | 47.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.3 | 1.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.3 | 0.8 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.3 | 1.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 0.8 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.3 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.3 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 4.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.3 | 2.8 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.3 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.3 | 1.3 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.3 | 0.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.3 | 50.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.3 | 1.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.3 | 2.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 1.0 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.2 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.2 | 32.8 | GO:0005179 | hormone activity(GO:0005179) |
| 0.2 | 1.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.2 | 0.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 0.5 | GO:0070698 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) type I activin receptor binding(GO:0070698) |
| 0.2 | 1.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.2 | 0.7 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.2 | 3.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 35.9 | GO:0005178 | integrin binding(GO:0005178) |
| 0.2 | 13.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.2 | 2.5 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 2.1 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 9.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 3.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 25.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.2 | 4.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.2 | 2.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.2 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.2 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.2 | 2.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.2 | 1.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 2.7 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.2 | 1.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 0.4 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.2 | 1.9 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.2 | 3.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 0.8 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.2 | 1.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.2 | 0.6 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.2 | 0.8 | GO:0004040 | amidase activity(GO:0004040) |
| 0.2 | 0.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.2 | 7.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 8.9 | GO:0017022 | myosin binding(GO:0017022) |
| 0.2 | 0.6 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.2 | 1.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 4.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 3.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 1.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.2 | 1.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.2 | 0.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.2 | 38.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 2.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 8.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 6.1 | GO:0003774 | motor activity(GO:0003774) |
| 0.2 | 0.6 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.2 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 0.6 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.2 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.2 | 4.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.2 | 0.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.2 | 2.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 0.7 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.2 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.2 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.2 | 6.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.2 | 1.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 5.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.2 | 4.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.2 | 1.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 3.4 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 4.4 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 14.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 0.5 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.2 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.2 | 0.5 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.2 | 37.5 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.2 | 0.5 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.2 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 5.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 7.8 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.2 | 4.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 6.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.9 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.1 | 1.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 6.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 1.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 0.1 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 1.6 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.7 | GO:0016297 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.1 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.1 | 1.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 5.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.1 | 5.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.1 | 2.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 1.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.1 | 1.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 2.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.1 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 4.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 0.6 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.1 | 7.4 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 4.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.3 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.1 | 1.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.8 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.1 | 2.9 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 2.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.1 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.5 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.1 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.3 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 1.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 11.8 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 5.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.3 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 4.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.3 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.1 | 0.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 10.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 22.4 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 0.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.1 | 0.4 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.1 | 6.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 26.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.1 | 0.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.2 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.1 | 0.3 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.1 | 0.3 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
| 0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 2.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 2.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 1.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 1.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 3.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.8 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.0 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.0 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.1 | GO:0051373 | telethonin binding(GO:0031433) FATZ binding(GO:0051373) |
| 0.0 | 0.1 | GO:0004794 | L-serine ammonia-lyase activity(GO:0003941) L-threonine ammonia-lyase activity(GO:0004794) |
| 0.0 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.0 | 0.1 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.0 | 2.0 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.0 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.0 | 0.1 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
| 0.0 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.0 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 1.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.0 | 4.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.0 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 18.3 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.0 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 10.8 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.0 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.0 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.1 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
| 0.0 | 0.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.0 | 0.0 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 7.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 1.2 | 34.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.9 | 18.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.8 | 15.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.8 | 32.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.8 | 17.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.8 | 45.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.8 | 10.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.7 | 34.1 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.7 | 8.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.7 | 18.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.7 | 48.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.7 | 17.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.6 | 47.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.6 | 11.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.6 | 176.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.6 | 15.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.5 | 4.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.5 | 42.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.5 | 35.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.5 | 23.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.5 | 25.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.5 | 10.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.4 | 13.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.4 | 5.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.4 | 10.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 2.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.4 | 5.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.4 | 24.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.4 | 11.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 23.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.4 | 14.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.4 | 6.0 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.4 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.4 | 33.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.3 | 3.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.3 | 12.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.3 | 14.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 22.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 1.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 3.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.3 | 4.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.3 | 10.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.3 | 9.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.3 | 4.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 10.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 37.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.3 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 14.3 | PID FGF PATHWAY | FGF signaling pathway |
| 0.2 | 103.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 3.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 2.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 4.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.2 | 54.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 1.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 11.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 5.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 3.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 3.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 39.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 6.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 1.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 6.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 5.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 2.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 1.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 1.9 | 1.9 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
| 1.7 | 5.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 1.6 | 35.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.4 | 23.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 1.3 | 6.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 1.2 | 45.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 1.1 | 17.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.1 | 32.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 1.1 | 39.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 1.0 | 53.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 1.0 | 2.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 1.0 | 24.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.0 | 48.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 1.0 | 2.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.9 | 12.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.9 | 64.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.8 | 21.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.8 | 18.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.8 | 68.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.8 | 14.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.8 | 10.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.7 | 11.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.7 | 8.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.7 | 10.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.7 | 30.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.7 | 4.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.6 | 1.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.6 | 21.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.6 | 16.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.6 | 87.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.6 | 17.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.6 | 8.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.5 | 10.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.5 | 28.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.5 | 30.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.5 | 1.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.5 | 10.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.5 | 31.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.5 | 25.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.5 | 2.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.5 | 8.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 22.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.4 | 10.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.4 | 7.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.4 | 12.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.4 | 11.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.4 | 16.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.4 | 15.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.4 | 18.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.4 | 3.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.4 | 1.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.4 | 25.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.4 | 8.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 4.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 20.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.4 | 13.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.4 | 10.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.4 | 9.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.4 | 25.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 3.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.3 | 8.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.3 | 5.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 20.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.3 | 12.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.3 | 17.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.3 | 6.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 14.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.3 | 9.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.3 | 32.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.3 | 4.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 3.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.3 | 6.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 4.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.2 | 2.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.2 | 2.7 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.2 | 17.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 6.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 1.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 5.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 2.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.2 | 3.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 8.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.2 | 2.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.2 | 7.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 2.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 28.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 3.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.1 | 0.2 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
| 0.1 | 9.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 3.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 3.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 2.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 3.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 6.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 4.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 7.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 1.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 16.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 9.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 1.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.0 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 0.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |